Skip to main content
Figure 5 | Orphanet Journal of Rare Diseases

Figure 5

From: Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: overlapping effects or limited therapeutic opportunity?

Figure 5

PRE + RSV treatment significantly reduced Iba-1 immunoreactivity in L4-L5 spinal cord lamina IX. (A) Representative microphotographs of L4-L5 spinal cord of wild type, untreated SOD1 (SOD1c), and PRE, RSV and PRE + RSV treated groups. (B) Percentage increase of Iba-1 immunoreactivity compared to wild type values. Values are mean ± SEM. **p < 0.01 vs. SOD1c.

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172